RE:RE:BuyoutI agree. With the addition of new drugs coming on screen the potential for exceeding forecasts has a much higher probability. Any potential buyer now sees this much more clearly and would want to capture the upside of this scenario. We the shareholders, might like this in the short term, but in reality we want MT to keep executing this plan as a public company for the foreseeable future. The upside here is far greater than $65 USD.... Let her run!!!!! GLTA